CinCor Pharma Total Current Liabilities

The latest total current liabilities for CINC is $10M as of September 2022. That compares with $12M in the prior-year period — down 11.8% year over year. Investors often review this figure alongside CinCor Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, CINC's total current liabilities moved from $12M to $10M — a 11.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CinCor Pharma's operating scale or balance-sheet position.

A total current liabilities figure of $10M for CINC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CINC's total current liabilities ($10M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.